Low-Carb diet plus drug shows promise for kidney patients – but study cut short
NCT ID NCT06094231
First seen Apr 19, 2026 · Last updated Apr 29, 2026 · Updated 2 times
Summary
This small pilot study aimed to see if a low-carb diet (50-100 grams of carbs per day) combined with the diabetes drug dapagliflozin could help people with chronic kidney disease and diabetes or prediabetes. Only 4 people were enrolled before the study was stopped early. The main goal was to check changes in blood sugar control (HbA1c) after 3 months, along with body composition and kidney function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
6th Medical Department with Nephrology and Dialysis, Clinik Ottakring
Vienna, 1160, Austria
Conditions
Explore the condition pages connected to this study.